drug resistant epilepsy participant will be define a having clinically document seizure with consistent eeg evidence a define by the 1981 international classification of epileptic seizure refractory to standard anti-seizure treatment for at least one year prior to enrolling in this study and with an average of at least one seizure per month this criterion will be establish by preliminary screening in the ninds clinical epilepsy section outpatient clinic under protocol 01-n-0139 and if necessary inpatient video- eeg monitoring seizure focus localization will be determine by standard clinical neurophysiologic and image study prior or concurrent enrollment in 01-n-0139 be require 